622Witnessing not required for administration under opioid

622 Witnessing not required for administration under opioid dependency treatment licence—Act, s190 (1) (a) The Act, section 53 (e) (Registers—witnessing administration of medicines) does not apply to the administration of buprenorphine or methadone under an opioid dependency treatment licence if section 471 is complied with in relation to the administration.

Part 14.6 Pharmacy medicines rural communities licences Part 14.6 Pharmacy medicines rural communities licences 625 Applications for pharmacy medicines rural communities An application for a pharmacy medicines rural communities licence must— (a) be in writing signed by the applicant; and (b) include— (i) the applicant’s full name, business address and telephone number; and (ii) the pharmacy medicines proposed to be sold under the licence.